Rachel Davenport

Co-founder & Director

Rachel Davenport is Co-founder and Director at AlphaBiolabs, the UK’s leading laboratory providing UKAS-accredited DNA, drug, and alcohol testing services for the legal sector. Since establishing the company in 2004, Rachel has continued to ensure that the range of services offered remain at the forefront of innovation and value, supporting family law professionals, social workers, and local authorities with court-approved solutions for family law cases.

For further information please contact AlphaBiolabs on 0333 600 1300, email media@alphabiolabs.com or visit www.alphabiolabs.co.uk

Co-founder & Director

For further information please contact AlphaBiolabs on 0333 600 1300, email media@alphabiolabs.com or visit www.alphabiolabs.co.uk

ARTICLES BY THIS AUTHOR

Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the company’s commitment to giving back to communities across the UK.

Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses the role that Drug, Alcohol and DNA testing can play in non-court dispute resolution

Rachel Davenport, Co-founder and Director at AlphaBiolabs, breaks down everything you need to know about AlphaBiolabs’ industry-leading laboratory testing services for legal matters.

Rachel Davenport, Co-founder and Director at AlphaBiolabs, discusses alcohol monitoring technology, and how it can be used to evidence levels and patterns of alcohol consumption or sobriety.

Show

Results

E-newsletter Sign-Up

MOVERS & SHAKERS

Read All

Mourant—Stephen Alexander

Jersey litigation lead appointed to global STEP Council

mfg Solicitors—nine trainees

Firm invests in future talent with new training cohort

360 Law Group—Anthony Gahan

Investment banking veteran appointed as chairman to drive global growth

NEWS

Read All

NLJ this week: Fraud claims climb as courts brace for AI threats

Charlie Mercer and Astrid Gillam of Stewarts crunch the numbers on civil fraud claims in the English courts, in this week's NLJ. New data shows civil fraud claims rising steadily since 2014, with the King’s Bench Division overtaking the Commercial Court as the forum of choice for lower-value disputes

NLJ this week: Pro bono power without the red tape

Bea Rossetto of the National Pro Bono Centre makes the case for ‘General Practice Pro Bono’—using core legal skills to deliver life-changing support, without the need for niche expertise—in this week's NLJ

NLJ this week: DNA evidence—justice on ice?

In this week's NLJ, Steven Ball of Red Lion Chambers unpacks how advances in forensic science finally unmasked Ryland Headley, jailed in 2025 for the 1967 rape and murder of 75-year-old Louisa Dunne. Preserved swabs and palm prints lay dormant for decades until DNA-17 profiling produced a billion-to-one match

NLJ this week: Traders’ convictions quashed in Libor shock

The Supreme Court issued a landmark judgment in July that overturned the convictions of Tom Hayes and Carlo Palombo, once poster boys of the Libor and Euribor scandal. In NLJ this week, Neil Swift of Peters & Peters considers what the ruling means for financial law enforcement

NLJ this week: Small firms call for tech clarity as AI looms

Small law firms want to embrace technology but feel lost in a maze of jargon, costs and compliance fears, writes Aisling O’Connell of the Solicitors Regulation Authority in this week's NLJ

Error message

Rachel Davenport

MOVERS & SHAKERS

Mourant—Stephen Alexander

mfg Solicitors—nine trainees

360 Law Group—Anthony Gahan